Cargando…
Inhibition of the alternative complement activation pathway in traumatic brain injury by a monoclonal anti-factor B antibody: a randomized placebo-controlled study in mice
BACKGROUND: The posttraumatic response to traumatic brain injury (TBI) is characterized, in part, by activation of the innate immune response, including the complement system. We have recently shown that mice devoid of a functional alternative pathway of complement activation (factor B-/- mice) are...
Autores principales: | Leinhase, Iris, Rozanski, Michal, Harhausen, Denise, Thurman, Joshua M, Schmidt, Oliver I, Hossini, Amir M, Taha, Mohy E, Rittirsch, Daniel, Ward, Peter A, Holers, V Michael, Ertel, Wolfgang, Stahel, Philip F |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1867808/ https://www.ncbi.nlm.nih.gov/pubmed/17474994 http://dx.doi.org/10.1186/1742-2094-4-13 |
Ejemplares similares
-
Reduced neuronal cell death after experimental brain injury in mice lacking a functional alternative pathway of complement activation
por: Leinhase, Iris, et al.
Publicado: (2006) -
Absence of the complement regulatory molecule CD59a leads to exacerbated neuropathology after traumatic brain injury in mice
por: Stahel, Philip F, et al.
Publicado: (2009) -
Complement in Human Disease
por: Flierl, Michael A., et al.
Publicado: (2013) -
Antiphospholipid antibodies harness innate effectors, neutrophils and an alternative pathway of complement, to induce fetal damage
por: Salmon, J, et al.
Publicado: (2003) -
Complement and autoimmunity: new insights into old questions
por: Holers, VM, et al.
Publicado: (2004)